Physician
Orthopaedic Surgery
Dr. Paul M. Keller, MD
|
|
Give Review
Paul Keller practices Orthopaedic Surgery. He graduated from Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He has 2 awards "Meaningful Use Stage 1 Certification" and "Top Doctors: Florida". Doctor Paul M. Keller, MD has written publications. He has 57 publications published with PubMed. The lastest paper is: 'One-step fluorescent probe product-enhanced reverse transcriptase assay.' Paul Keller accepts Medicare payments and is registered with Medicare.gov.
Publications
- Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster.
- Azepanone-based inhibitors of human cathepsin S: Optimization of selectivity via the P2 substituent.
- A real-time PCR assay to identify and Discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and co...
- Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.
- Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors.
- A high-throughput screen for endothelial lipase using HDL as substrate.
- Solution state characterization of amyloid beta-derived diffusible ligands.
- A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalationa...
- Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and st...
- A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
- Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.
- Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adeno...
- Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
- Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
- Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.
- Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing ...
- Discovery of a novel and potent class of FabI-directed antibacterial agents.
- Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
- Role of caspases in human renal proximal tubular epithelial cell apoptosis.
- Structure-based combinatorial library design: Discovery of non-peptidic inhibitors of caspases 3 and 8.
- An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.
- Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
- Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus.
- Potent and selective nonpeptide inhibitors of caspases 3 and 7.
- Fast characterization of intact proteins using a high-throughput eight-channel parallel liquid chromatography/mass spectrometry system.
- Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality.
- Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro.
- Apoptosis in polycystic kidney Disease: involvement of caspases.
- Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.
- A substrate combinatorial array for caspases.
- The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human kerati...
- One-step fluorescent probe product-enhanced reverse transcriptase assay.
- Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind Discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinan...
- Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon.
- Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.
- Identification of HIV vaccine candidate peptides by screening random phage epitope libraries.
- Cloning of the cDNA and expression of moubatin, an inhibitor of platelet aggregation.
- Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae.
- An inhibitor of collagen-stimulated platelet activation from the salivary glands of the Haementeria officinalis leech. II. Cloning of the cDNA and expression.
- Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.
- Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties.
- Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus.
- Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
- Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus.
- Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
- Varicella-zoster virus as a live vector for the expression of foreign genes.
- Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus.
- Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glyco...
- Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.
- Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus.
- New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.
- Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties.
- Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical ...
- Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.
- Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Meth Hospital Ind
Indiana University Med Center
Thomas Jefferson University
Procedures Preformed
- Disc Replacement
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Dural Repair or Other Spinal Spinal Cord Repair
- Epidural Block, Facet Blocks
- View All
Conditions Treated
- Adhesive Capsulitis
- Ankylosing Spondylitis
- Ataxia
- Back Pain
- View All
Doctors Specialties
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Top Doctors: Florida
Education
-
Thomas Jefferson University -
Indiana University School of Medicine -
University of Chicago Pritzker School of Medicine
Drug Facts
| NPI NUMBER | 1689677817 | |
| NPPES Provider LastName | KELLER | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 329013235 | |
| NPPES Provider State | FL | |
| Specialty Description | Orthopedic Surgery | |
| Total Claim Count | 921.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 422.0 | |
| Percent Opioid Claims | 45.82 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689677817 |
| Last Name Of The Provider | KELLER |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Carlos K. Woodward, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Hynes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia A. Baumann, DO |
|
|
Dr. Andrew D. Schmidt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn E. Bryan Jr., MD |